DE3639418A1 - Nikotinhaltiges mittel - Google Patents

Nikotinhaltiges mittel

Info

Publication number
DE3639418A1
DE3639418A1 DE19863639418 DE3639418A DE3639418A1 DE 3639418 A1 DE3639418 A1 DE 3639418A1 DE 19863639418 DE19863639418 DE 19863639418 DE 3639418 A DE3639418 A DE 3639418A DE 3639418 A1 DE3639418 A1 DE 3639418A1
Authority
DE
Germany
Prior art keywords
capsule
nicotine
composition according
liquid
chewing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19863639418
Other languages
German (de)
English (en)
Other versions
DE3639418C2 (enExample
Inventor
Des Erfinders Auf Nennung Verzicht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FORSCHUNGSGESELLSCHAFT RAUCHEN
Original Assignee
FORSCHUNGSGESELLSCHAFT RAUCHEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19863645036 priority Critical patent/DE3645036A1/de
Application filed by FORSCHUNGSGESELLSCHAFT RAUCHEN filed Critical FORSCHUNGSGESELLSCHAFT RAUCHEN
Priority to DE19863639418 priority patent/DE3639418A1/de
Priority to BR8707879A priority patent/BR8707879A/pt
Priority to AU81712/87A priority patent/AU622101B2/en
Priority to PCT/DE1987/000507 priority patent/WO1988003803A1/de
Priority to DE8787907302T priority patent/DE3776574D1/de
Priority to EP87907302A priority patent/EP0324794B1/de
Priority to JP62506732A priority patent/JP2602043B2/ja
Priority to AT87907302T priority patent/ATE72114T1/de
Priority to CN87107852A priority patent/CN87107852A/zh
Publication of DE3639418A1 publication Critical patent/DE3639418A1/de
Priority to DK198803858A priority patent/DK173353B1/da
Application granted granted Critical
Publication of DE3639418C2 publication Critical patent/DE3639418C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19863639418 1986-11-18 1986-11-18 Nikotinhaltiges mittel Granted DE3639418A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE19863639418 DE3639418A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
DE19863645036 DE3645036A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
AU81712/87A AU622101B2 (en) 1986-11-18 1987-11-06 Oral administration capsule with a nicotine-containing fluid medium
PCT/DE1987/000507 WO1988003803A1 (fr) 1986-11-18 1987-11-06 Capsule a administration orale avec un milieu fluide contenant de la nicotine
DE8787907302T DE3776574D1 (de) 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel.
EP87907302A EP0324794B1 (de) 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, flüssigen mittel
BR8707879A BR8707879A (pt) 1986-11-18 1987-11-06 Capsula de administracao oral com uma substancia liquida contendo nicotina
JP62506732A JP2602043B2 (ja) 1986-11-18 1987-11-06 ニコチン含有流動媒質を含む口経投与用カプセル
AT87907302T ATE72114T1 (de) 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel.
CN87107852A CN87107852A (zh) 1986-11-18 1987-11-18 含烟碱液态制剂的口服胶囊
DK198803858A DK173353B1 (da) 1986-11-18 1988-07-08 Kapsel med nikotinholdigt flydende medium til oral indtagelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863639418 DE3639418A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel

Publications (2)

Publication Number Publication Date
DE3639418A1 true DE3639418A1 (de) 1988-06-09
DE3639418C2 DE3639418C2 (enExample) 1989-08-03

Family

ID=6314221

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19863639418 Granted DE3639418A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
DE19863645036 Granted DE3645036A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
DE8787907302T Expired - Fee Related DE3776574D1 (de) 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE19863645036 Granted DE3645036A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
DE8787907302T Expired - Fee Related DE3776574D1 (de) 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel.

Country Status (9)

Country Link
EP (1) EP0324794B1 (enExample)
JP (1) JP2602043B2 (enExample)
CN (1) CN87107852A (enExample)
AT (1) ATE72114T1 (enExample)
AU (1) AU622101B2 (enExample)
BR (1) BR8707879A (enExample)
DE (3) DE3639418A1 (enExample)
DK (1) DK173353B1 (enExample)
WO (1) WO1988003803A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4440563A1 (de) * 1994-11-12 1996-05-15 Herzog Sen Rolf Verfahren und Mittel zum Genuß von Tabak - Nikotin unter Vermeidung schädlicher Verbrennungs - Derivate

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5846983A (en) * 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6211194B1 (en) * 1998-04-30 2001-04-03 Duke University Solution containing nicotine
US6268386B1 (en) * 1998-06-25 2001-07-31 Marshall Anlauf Thompson Nicotine beverage
GB2338896B (en) 1998-07-02 2003-05-21 Reckitt & Colmann Prod Ltd Chewable Capsules
BR0012793A (pt) 1999-07-28 2002-04-30 Univ Leland Stanford Junior Métodos para indução de angiogênese pela administração de nicotina ou outro agonista de receptor de nicotina
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
SE0104388D0 (sv) 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
WO2005007068A1 (en) * 2003-07-22 2005-01-27 The Kiwigel Company Limited Nicotine packaging system
NO20042835D0 (no) * 2004-07-05 2004-07-05 Nils-Erik Skeide Innkapslet tobakksroyk
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
EP2322168A1 (en) * 2007-04-02 2011-05-18 Parkinson's Institute Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
CN101249130B (zh) * 2008-04-11 2011-06-15 桂林商源植物制品有限公司 一种戒烟并缓解戒烟综合症的药用或保健组合物
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
EP3297676A2 (en) * 2015-05-22 2018-03-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Combination of trpm8-agonist and nachr-agonist for treatment of obesity and related disorders and for weight reduction
CN105341990A (zh) * 2015-12-16 2016-02-24 浙江中烟工业有限责任公司 一种提升电子烟生理满足感的电子烟烟液
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1528391A (en) * 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
DE3401763A1 (de) * 1983-01-21 1984-07-26 Aktiebolaget Leo, Helsingborg Tabakrauchersatzzubereitung zur verabreichung durch die nase
DE3438284A1 (de) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nikotinhaltiges depotpflaster
DE3606892A1 (de) * 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (enExample) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds
BE899037A (fr) * 1984-02-29 1984-06-18 Trenker Ady Composition a sucer permettant de cesser de fumer
EP0186502A3 (en) * 1984-12-25 1986-12-10 Jano Tyroler Flavor capsule and method of preparing same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1528391A (en) * 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
DE3401763A1 (de) * 1983-01-21 1984-07-26 Aktiebolaget Leo, Helsingborg Tabakrauchersatzzubereitung zur verabreichung durch die nase
DE3438284A1 (de) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nikotinhaltiges depotpflaster
DE3606892A1 (de) * 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Drug and Alcohol Dependence, 13, 1984, S.209-213 *
GSTIRNER, F.: Einführung in die Verfahrenstechnik der Arzneiformung, 1973, S.177-181 *
HELLWIG, B.: Moderne Arzneimittel, 1980, S.815-816 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4440563A1 (de) * 1994-11-12 1996-05-15 Herzog Sen Rolf Verfahren und Mittel zum Genuß von Tabak - Nikotin unter Vermeidung schädlicher Verbrennungs - Derivate

Also Published As

Publication number Publication date
DE3645036A1 (de) 1989-01-05
DK385888A (da) 1988-07-08
DK173353B1 (da) 2000-08-07
DK385888D0 (da) 1988-07-08
JP2602043B2 (ja) 1997-04-23
DE3639418C2 (enExample) 1989-08-03
EP0324794B1 (de) 1992-01-29
AU8171287A (en) 1988-06-16
ATE72114T1 (de) 1992-02-15
JPH02501304A (ja) 1990-05-10
DE3776574D1 (de) 1992-03-12
AU622101B2 (en) 1992-04-02
BR8707879A (pt) 1989-10-03
CN87107852A (zh) 1988-06-22
EP0324794A1 (de) 1989-07-26
WO1988003803A1 (fr) 1988-06-02

Similar Documents

Publication Publication Date Title
DE3639418A1 (de) Nikotinhaltiges mittel
DE69012823T2 (de) Hilfsmittel zum einstellen des rauchens oder zur verwendung in nichtrauchergebieten.
DE3650189T2 (de) Mittel zur nichsystemischen Verabreichung von Sedativa und Analgetika.
DE3856096T2 (de) Verfahren zur Behandlung der mit dem Rauchstop verbundenen Entwöhnungssymptome sowie Mittel zur Verwendung in diesem Verfahren
DE3601787C2 (enExample)
DE3401763C2 (enExample)
Morice et al. Effect of inhaled menthol on citric acid induced cough in normal subjects.
DE69325643T2 (de) Zusammensetzung zur raucherentwöhnung
EP0796103B1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE69305759T2 (de) Erzeugnis zur Unterstützung für das Aufgeben des Rauchens
EP2029097A2 (de) Antidepressiva-kombinations-wafer
DE68928415T2 (de) Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
DE102017100042B4 (de) Wirkstoffbeladbares Saugstück, Schnuller und Verwendung einer Arzneiform in einem Schnuller
AT501560A1 (de) Verwendung von kräuterzigaretten
US5716635A (en) Plantago major transdermal patch for use in treating a tobacco or nicotine habit
EP0561307B1 (de) Antirauchmittel
DE69402241T2 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
DE68922225T2 (de) Verdichtete pulverheilmittel.
EP1524982B1 (de) Medikament und verfahren zur verringerung des alkohol-und/oder tabakkonsums
DE102017012248B3 (de) Schnuller umfassend eine austauschbare kartusche, und verwendung einer arzneiform in einem schnuller
EP3383373A2 (de) Präparat für das pharmakologische vitalisieren, sedieren oder eine chronologische kombination hiervon mittels zeitgesteuerter freisetzungskinetik sowie einrichtung zur anwendung des präparates
AT153343B (de) Gerät als Ersatz für das Tabakrauchen.
EP2441333A1 (de) Kaufähige Tablette
WO2013079216A2 (de) Zahnreinigungsmittel
Murthy et al. Hiccups following steroid oral mini-pulse (OMP) therapy

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
AH Division in

Ref country code: DE

Ref document number: 3645036

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
AH Division in

Ref country code: DE

Ref document number: 3645036

Format of ref document f/p: P

8339 Ceased/non-payment of the annual fee